Related Experiment Video

Updated: Mar 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

10.1K

Tumor Protein (TP)-p53 Members as Regulators of Autophagy in Tumor Cells upon Marine Drug Exposure

Edward A Ratovitski1

  • 1Head and Neck Cancer Research Division, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. eratovi1@jhmi.edu.

Marine Drugs
|August 19, 2016
PubMed

Insights

Marine compounds like Chromomycin A2, Psammaplin A, and Ilimaquinone show promise in cancer treatment by activating autophagy. These compounds regulate autophagic signaling intermediates via tumor protein p53 family members in various cancer cells.

Area of Science:

  • Molecular oncology
  • Marine natural products chemistry
  • Cancer cell biology

Background:

  • Autophagic pathways are crucial targets for novel cancer chemotherapeutics and overcoming chemoresistance.
  • Marine-derived compounds exhibit anti-cancer properties, including reduced tumor cell growth and induction of autophagic flux.
  • Understanding the molecular mechanisms of these marine compounds is essential for therapeutic development.

Purpose of the Study:

  • To investigate the effect of specific marine compounds (Chromomycin A2, Psammaplin A, Ilimaquinone) on autophagic signaling in cancer cells.
  • To elucidate the role of tumor protein (TP)-p53 family members in the transcriptional regulation of autophagic intermediates by these marine compounds.
  • To assess the potential of these compounds as chemoresistance-preventing agents.

Main Methods:

  • In vitro studies using human squamous cell carcinoma, glioblastoma, and colorectal carcinoma cell lines.
  • Quantitative real-time PCR (qPCR) for gene expression analysis.
  • Luciferase reporter promoter assays to study transcriptional activity.
  • Chromatin immunoprecipitation (ChIP) to identify TP53 family protein binding to promoter regions.
  • Gene silencing of TP53 family members.

Main Results:

  • Selected marine compounds induced the expression of autophagic signaling intermediates in tested cancer cell lines.
  • Transcriptional regulation by tumor protein (TP)-p53 family members was identified as the mechanism of action.
  • qPCR, luciferase assays, and ChIP confirmed the involvement of TP53 family proteins in regulating autophagic gene expression.
  • Silencing TP53 family members affected the induction of autophagic signaling by the marine compounds.

Conclusions:

  • Marine compounds Chromomycin A2, Psammaplin A, and Ilimaquinone modulate autophagic signaling in cancer cells.
  • TP53 family proteins play a key role in mediating the transcriptional effects of these marine compounds on autophagy.
  • These findings support the potential of marine compounds as therapeutic agents targeting cancer and chemoresistance through modulation of autophagic pathways.
Keywords:
autophagycancermarine drugsp53 family memberstranscription

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

308
Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

2.9K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K